A vs APUS: Which Stock is Better?
Side-by-side comparison of Agilent Technologies Inc and Apimeds Pharmaceuticals Us Inc in 2026
A
Agilent Technologies Inc
$121.87
APUS
Apimeds Pharmaceuticals Us Inc
$1.88
Key Metrics Comparison
| Metric | A | APUS | Winner |
|---|---|---|---|
| Market Cap | $34.47B | $23.64M | A |
| P/E Ratio | 26.90 | N/A | A |
| EPS (TTM) | $4.53 | $N/A | A |
| Revenue Growth | 0.1% | 0.0% | A |
| Gross Margin | 52.3% | 0.0% | A |
Analyze A
Full quant analysis
Analyze APUS
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is A or APUS a better investment?
Comparing A and APUS: Agilent Technologies Inc has a market cap of $34.47B while Apimeds Pharmaceuticals Us Inc has $23.64M. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between A and APUS?
A (Agilent Technologies Inc) and APUS (Apimeds Pharmaceuticals Us Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: A or APUS?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: A or APUS?
A has higher revenue growth at 0.1% vs 0.0% for APUS.
Which company is more profitable: A or APUS?
Agilent Technologies Inc (A) has higher gross margins at 52.3% compared to 0.0% for APUS.
Which is the larger company: A or APUS?
Agilent Technologies Inc (A) is larger with a market cap of $34.47B compared to $23.64M for APUS.
Should I buy A or APUS in 2026?
Both A and APUS have investment merit. A trades at $121.87 while APUS trades at $1.88. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between A and APUS stock?
Key differences: Market Cap ($34.47B vs $23.64M), P/E Ratio (26.9x vs N/A), Revenue Growth (0.1% vs 0.0%), Gross Margin (52.3% vs 0.0%).